The Drug Regulatory Authority of Pakistan (DRAP) has issued an urgent recall for five drug products due to contamination issues. The affected products include Cestonil Plus syrup, Texcol DM 10mg/5ml syrup, Speczine 5mg/5ml Syrup, Aphylin Syrup, and Zolint Suspension. The contamination with ethylene glycol and di-ethylene glycol, both identified by the Directorate of Drugs Control (DDC), Punjab, has led to these products being classified as substandard by Drug Testing Laboratories (DTLs).
Recall Details:
| Product | Batch Number | Composition | Manufacturer |
|---|---|---|---|
| Cestonil Plus Syrup | 061357 | Thiamine 1.75mg, Riboflavin 2.62mg, Pyridoxine 1.54mg, Nicotinamide 10.50mg | M/s Razzee Therapeutics, Lahore |
| Texcol DM 10mg/5ml Syrup | 09980 | Dextromethorphan | M/s Razzee Therapeutics, Lahore |
| Speczine 5mg/5ml Syrup | 280 287 | Promethazine | M/s Spectrum Laboratories, Lahore |
| Aphylin Syrup | 24B056 | Aminophylline 32mg, Diphenhydramine 8mg, Ammonium HCl 30mg | M/s Obsons Pharmaceuticals, Lahore |
| Zolint Suspension | 24003 | Furazolidone 25mg/5ml, Metronidazole 75mg/5ml | M/s Libra (Private) Ltd, Peshawar |
Health Risks:
Contamination with di-ethylene glycol (DEG) and ethylene glycol (EG) poses serious health risks. These chemicals are toxic and can lead to severe health complications if ingested.
Action Required:
DRAP advises health professionals and consumers to avoid using the aforementioned products and to check for the batch numbers listed. The recall is part of a broader government crackdown against spurious and contaminated drugs to ensure public safety.
Leave a Comment